Angiodynamics (ANGO) Net Income (2010 - 2026)
Angiodynamics' (ANGO) quarterly Net Income came in at -$11.4 million in Q2 2026, down 88.51% YoY from -$99.3 million in Q2 2025, and down 41.08% on a QoQ basis from -$8.1 million in Q1 2026.
Angiodynamics (ANGO) Net Income (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Net Income data on file, last reported at -$11.4 million in Q2 2026.
- Quarterly Net Income fell 88.51% year-over-year to -$11.4 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$36.7 million (down 8.09% YoY) and the FY2026 annual result came in at -$36.7 million, down 8.09% from the prior year.
- Net Income slipped to -$11.4 million in Q2 2026, from -$8.1 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $45.9 million in Q3 2023 to a low of -$187.7 million in Q1 2024.
- A 5-year average of -$17.7 million and a median of -$10.1 million in 2023 frame the typical range for Net Income.
- Annual changes were most pronounced in 2023 — Net Income jumped 452.85% — and 2024, when it slumped 1879.29%.
- Tracing ANGO's Net Income over 5 years: stood at -$8.5 million in 2022, then slumped by 242.3% to -$29.0 million in 2023, then jumped by 63.03% to -$10.7 million in 2024, then soared by 40.86% to -$6.4 million in 2025, then plunged by 79.61% to -$11.4 million in 2026.
- The last three Net Income figures came in at -$11.4 million (Q2 2026), -$8.1 million (Q1 2026), and -$6.4 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | -11.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -11.41 Mn |
| Feb 28, 2026 | -8.08 Mn |
| Nov 30, 2025 | -6.35 Mn |
| Aug 31, 2025 | -10.90 Mn |
| May 31, 2025 | -6.05 Mn |
| Feb 28, 2025 | -4.41 Mn |
| Nov 30, 2024 | -10.74 Mn |
| Aug 31, 2024 | -12.80 Mn |
| May 31, 2024 | -13.45 Mn |
| Feb 29, 2024 | -187.74 Mn |
| Nov 30, 2023 | -29.05 Mn |
| Aug 31, 2023 | 45.88 Mn |
| May 31, 2023 | -21.47 Mn |
| Feb 28, 2023 | -9.49 Mn |
| Nov 30, 2022 | -8.49 Mn |
| Aug 31, 2022 | -13.00 Mn |
| May 31, 2022 | -6.27 Mn |
| Feb 28, 2022 | -4.96 Mn |
| Nov 30, 2021 | -8.35 Mn |
| Aug 31, 2021 | -6.97 Mn |